ASR Guidance Development May Be Supported By AdvaMed FAQ Document
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed plans to revise a set of frequently asked questions related to analyte specific reagents that could be used as a starting point for an FDA guidance document, following a recent meeting with the agency